Microglial polarization in TBI: Signaling pathways and influencing pharmaceuticals

YF Li, X Ren, L Zhang, YH Wang… - Frontiers in aging …, 2022 - frontiersin.org
Traumatic brain injury (TBI) is a serious disease that threatens life and health of people. It
poses a great economic burden on the healthcare system. Thus, seeking effective therapy to …

Treatment of neonatal hypoxic-ischemic encephalopathy with erythropoietin alone, and erythropoietin combined with hypothermia: history, current status, and future …

DE Oorschot, RJ Sizemore, AR Amer - International journal of molecular …, 2020 - mdpi.com
Perinatal hypoxic-ischemic encephalopathy (HIE) remains a major cause of morbidity and
mortality. Moderate hypothermia (33.5° C) is currently the sole established standard …

Hypoxic ischemic encephalopathy: pathophysiology and experimental treatments

KA Allen, DH Brandon - Newborn and Infant Nursing Reviews, 2011 - Elsevier
Hypoxic ischemic encephalopathy (HIE) is a serious birth complication affecting full-term
infants; 40% to 60% of affected infants die by 2 years old or have severe disabilities. Most …

Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection

V Rangarajan, SE Juul - Pediatric neurology, 2014 - Elsevier
Background In the last two decades, there has been considerable evolution in
understanding the role of erythropoietin in neuroprotection. Erythropoietin has both …

[HTML][HTML] Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy

J Chen, KM Connor, CM Aderman… - … & visual science, 2009 - tvst.arvojournals.org
purpose. Erythropoietin (EPO), an oxygen-regulated hormone stimulating erythrocyte
production, was recently found to be critical for retinal angiogenesis. EPO mRNA expression …

Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia

MA van der Kooij, F Groenendaal, A Kavelaars… - Brain research …, 2008 - Elsevier
Besides its established function in erythropoiesis, erythropoietin (EPO) is currently also
appreciated for its neuroprotective effects. The detrimental sequelae of prolonged cerebral …

An approach to using recombinant erythropoietin for neuroprotection in very preterm infants

JC Fauchere, C Dame, R Vonthein, B Koller, S Arri… - …, 2008 - publications.aap.org
OBJECTIVE. Erythropoietin has been shown to be protective against hypoxic-ischemic and
inflammatory injuries in cell culture, animal models of brain injury, and clinical trials of adult …

Erythropoietin sustains cognitive function and brain volume after neonatal stroke

FF Gonzalez, R Abel, CR Almli, D Mu… - Developmental …, 2009 - karger.com
Neonatal stroke leads to mortality and severe morbidity, but there currently is no effective
treatment. Erythropoietin (EPO) promotes cytoprotection and neurogenesis in the short term …

Exploring perinatal asphyxia by metabolomics

E Locci, G Bazzano, R Demontis, A Chighine, V Fanos… - Metabolites, 2020 - mdpi.com
Brain damage related to perinatal asphyxia is the second cause of neuro-disability
worldwide. Its incidence was estimated in 2010 as 8.5 cases per 1000 live births worldwide …

Erythropoietin for neonatal brain injury: opportunity and challenge

T **ong, Y Qu, D Mu, D Ferriero - International Journal of Developmental …, 2011 - Elsevier
Neonatal brain injury, caused by perinatal hypoxia-ischemia and extreme prematurity,
remains a great challenge for prevention and treatment. There is no effective treatment for …